OGA, O-GlcNAcase, 10724

N. diseases: 140; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0221292
Disease: Basophilic leukemia
Basophilic leukemia
0.030 Biomarker disease BEFREE The inhibitory effects of the isolated constituents on β-hexosaminidase release from RBL-2H3 cells were examined, and compounds 1, 5, 8 and 11 exhibited potent inhibitory activity with IC<sub>50</sub> values between 0.05 and 4.28 μM. 30953890 2019
CUI: C0221292
Disease: Basophilic leukemia
Basophilic leukemia
0.030 Biomarker disease BEFREE Activated BLCs and BMMCs released copious granule-related mediators (histamine and β-hexosaminidase), which was reduced by palbociclib in a concentration-dependent manner. 31429774 2019
CUI: C0221292
Disease: Basophilic leukemia
Basophilic leukemia
0.030 Biomarker disease BEFREE Carbachol (CCh) caused a dose-dependent release of beta-hexosaminidase and an increase in the production of inositol 1,4,5-trisphosphate (IP3) in RBL-2H3 cells transfected with m2 mAChR cDNA (RBL-m2 cells). 15359086 2004